{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:45:42Z","timestamp":1789789542058,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.atherosclerosis.2013.07.003","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T14:04:32Z","timestamp":1373983472000},"page":"191-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Epigenetic signatures and vascular risk in type 2 diabetes: A clinical perspective"],"prefix":"10.1016","volume":"230","author":[{"given":"Francesco","family":"Paneni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Felix","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world\u2013a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999\u20132010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrendo.2009.213","article-title":"Residual microvascular risk in diabetes: unmet needs and future directions","volume":"6","author":"Fioretto","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib6","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"Gerstein","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the STENO type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"Mrc\/bhf heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2337\/diacare.28.5.1151","article-title":"Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: anglo-Scandinavian cardiac outcomes trial\u2013lipid-lowering arm (ASCOT-LLA)","volume":"28","author":"Sever","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2174\/157016112803520864","article-title":"Mechanisms of diabetic dyslipidemia: relevance for atherogenesis","volume":"10","author":"Arca","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib16","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib18","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/jc.2008-1824","article-title":"Clinical review 2: the \u201cmetabolic memory\u201d: is more than just tight glucose control necessary to prevent diabetic complications?","volume":"94","author":"Ceriello","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11906-011-0205-z","article-title":"Antihypertensive therapy in diabetes: the legacy effect and RAAS blockade","volume":"13","author":"Volpe","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy. Part I","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2013.07.003_bib22","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.hjr.0000368193.24732.66","article-title":"Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes","volume":"17","author":"Ceriello","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib23","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCRESAHA.111.300233","article-title":"Mitochondria and endothelial function","volume":"112","author":"Kluge","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCULATIONAHA.112.127514","article-title":"Protein kinase c-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus","volume":"127","author":"Tabit","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase c isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib26","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","article-title":"Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase c and NAD(P)H-oxidase activation","volume":"52","author":"Quagliaro","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/ATVBAHA.107.156059","article-title":"Final common molecular pathways of aging and cardiovascular disease: role of the p66shc protein","volume":"28","author":"Cosentino","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Giorgio","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib29","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1073\/pnas.0609656104","article-title":"Genetic deletion of p66(shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress","volume":"104","author":"Camici","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jc.2004-1283","article-title":"Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress","volume":"90","author":"Pagnin","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCRESAHA.112.266593","article-title":"Gene silencing of the mitochondrial adaptor p66(shc) suppresses vascular hyperglycemic memory in diabetes","volume":"111","author":"Paneni","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-kappaB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCULATIONAHA.111.054346","article-title":"Blockade of the nuclear factor-kappaB pathway in the endothelium prevents insulin resistance and prolongs life spans","volume":"125","author":"Hasegawa","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1161\/CIRCULATIONAHA.111.090134","article-title":"Endothelial nuclear factor kappaB in obesity and aging: is endothelial nuclear factor kappaB a master regulator of inflammation and insulin resistance?","volume":"125","author":"Kim","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib35","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/db11-1824","article-title":"Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCbeta activation in diabetes","volume":"61","author":"Mima","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/hh0102.102359","article-title":"Inhibition of protein kinase cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans","volume":"90","author":"Beckman","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10557-008-6144-5","article-title":"Selective PKCbeta inhibition with ruboxistaurin and endothelial function in type-2 diabetes mellitus","volume":"23","author":"Mehta","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MOL.0b013e32834f319d","article-title":"Glycemic memory","volume":"23","author":"El-Osta","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib39","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1089\/ars.2012.4926","article-title":"The role of redox signaling in epigenetics and cardiovascular disease","volume":"18","author":"Kim","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib40","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.111.085787","article-title":"Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?","volume":"125","author":"Napoli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib41","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12265-012-9380-9","article-title":"Chromatin modifications associated with diabetes","volume":"5","author":"Keating","year":"2012","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.110.223552","article-title":"Epigenetics: mechanisms and implications for diabetic complications","volume":"107","author":"Cooper","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvr201","article-title":"Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage","volume":"92","author":"Napoli","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib45","doi-asserted-by":"crossref","first-page":"F14","DOI":"10.1152\/ajprenal.00200.2010","article-title":"The role of epigenetics in the pathology of diabetic complications","volume":"299","author":"Villeneuve","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","article-title":"Repression of p66shc expression by sirt1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction","volume":"109","author":"Zhou","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/db11-0416","article-title":"Sirtuin 1-mediated cellular metabolic memory of high glucose via the lkb1\/ampk\/ros pathway and therapeutic effects of metformin","volume":"61","author":"Zheng","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib48","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M311786200","article-title":"In\u00a0vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions","volume":"279","author":"Miao","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib49","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.2337\/db08-0645","article-title":"Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes","volume":"57","author":"Miao","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib50","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.0803623105","article-title":"Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes","volume":"105","author":"Villeneuve","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCRESAHA.108.175190","article-title":"Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice","volume":"103","author":"Reddy","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib52","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/db08-1666","article-title":"Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail","volume":"58","author":"Brasacchio","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib53","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib54","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.112.000412","article-title":"Agreement among cardiovascular disease risk calculators","volume":"127","author":"Allan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib55","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/463596b","article-title":"Project set to map marks on genome","volume":"463","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gat020","article-title":"Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life","author":"Lehnen","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib57","doi-asserted-by":"crossref","first-page":"565160","DOI":"10.1155\/2012\/565160","article-title":"Cardiovascular disease risk in the offspring of diabetic women: the impact of the intrauterine environment","volume":"2012","author":"Marco","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib58","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM198302033080502","article-title":"Excessive obesity in offspring of pima Indian women with diabetes during pregnancy","volume":"308","author":"Pettitt","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib59","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/diab.37.5.622","article-title":"Congenital susceptibility to NIDDM. Role of intrauterine environment","volume":"37","author":"Pettitt","year":"1988","journal-title":"Diabetes"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.atherosclerosis.2013.07.003_bib60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000337363","article-title":"Why are genetics important for nutrition? Lessons from epigenetic research","volume":"60","author":"Ruemmele","year":"2012","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.maturitas.2011.06.017","article-title":"Hungry in the womb: what are the consequences? Lessons from the Dutch famine","volume":"70","author":"Roseboom","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib62","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4161\/epi.4.8.10265","article-title":"The epigenome: archive of the prenatal environment","volume":"4","author":"Heijmans","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12272-013-0020-y","article-title":"Molecular mechanisms of central leptin resistance in obesity","volume":"36","author":"Jung","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib64","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/schbul\/sbn096","article-title":"Prenatal nutritional deficiency and risk of adult schizophrenia","volume":"34","author":"Brown","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/ars.2011.4381","article-title":"Nutrition, epigenetics, and metabolic syndrome","volume":"17","author":"Wang","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib66","doi-asserted-by":"crossref","DOI":"10.2337\/db12-1648","article-title":"Sirt1, p66shc and set7\/9 in vascular hyperglycemic memory: bringing all the strands together","author":"Paneni","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib67","doi-asserted-by":"crossref","first-page":"29318","DOI":"10.1074\/jbc.M002725200","article-title":"Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation","volume":"275","author":"Yi","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib68","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/cvr\/cvr250","article-title":"Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc","volume":"92","author":"Kim","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2013.02.019","article-title":"The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation","volume":"228","author":"Krishna","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11357-009-9104-5","article-title":"Could sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions?","volume":"31","author":"Wakeling","year":"2009","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib71","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans","volume":"14","author":"Timmers","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib72","first-page":"596","article-title":"Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease","volume":"12","author":"Lekakis","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib73","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.numecd.2010.03.003","article-title":"Acute resveratrol supplementation improves flow-mediated dilatation in overweight\/obese individuals with mildly elevated blood pressure","volume":"21","author":"Wong","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib74","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1074248408329608","article-title":"Currying the heart: curcumin and cardioprotection","volume":"14","author":"Srivastava","year":"2009","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2013.07.003_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201200791","article-title":"Targeted delivery of curcumin for treating type 2 diabetes","author":"Maradana","year":"2013","journal-title":"Mol Nutr Food Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501300395X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501300395X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T08:25:56Z","timestamp":1563438356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501300395X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S002191501300395X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.07.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic signatures and vascular risk in type 2 diabetes: A clinical perspective","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}